Wetenschappelijke publicaties van Bordet

Wetenschappelijke publicaties van Bordet

  • Mismatch repair deficiency/microsatellite instability (dMMR/MSI-H) in rectal cancer patients treated with standard neoadjuvant therapy: a systematic review and meta-analysis.

  • Auteurs Ricco G, Gallio C, Benhima N, Assaf I, Laethem JV, Sclafani F
  • Auteurs (entité) SCLAFANI FRANCESCO
  • Revue Cancer Treat Rev
  • Date de publication 2025-10
Mismatch repair deficiency/microsatellite instability (dMMR/MSI-H) in rectal cancer patients treated with standard neoadjuvant therapy: a systematic review and meta-analysis.
  • Stereotactic body radiation therapy for inoperable non-metastasized pancreatic adenocarcinoma: a randomised phase II study (TORPEDO).

  • Auteurs Stas D, Vandamme T, Roeyen G, Reynders D, Demey W, Stellamans K, Bussels B, Hutsebaut I, Maurissen I, Bouchart C, Berbée M, Lallemand F, Poels H, Thomas M, Cuyle PJ, Bulens P, Verboven K, Martens M, Weytjens R, Joye I
  • Auteurs (entité) BOUCHART CHRISTELLE
  • Revue BMC Cancer
  • Date de publication 2025-10
Stereotactic body radiation therapy for inoperable non-metastasized pancreatic adenocarcinoma: a randomised phase II study (TORPEDO).
  • 35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.

  • Auteurs Moreau P, Hulin C, Talbot A, Demarquette H, Caillot L, Chalopin T, Bobin A, Manier S, Leleu X, Karlin L, Caillot D, Sonntag C, Feugier P, Roussel M, Gounot R, Macro M, Mohty M, Garderet L, Tiab M, Orsini-Piocelle F, Vincent L, Meuleman N, Fontan J, Montes L, Vekemans MC, Escoffre-Barbe M, Eveillard JR, Schiano de Colella JM, Lambert J, Mary JY, Fermand JP, Arnulf B, Corre J, Avet-Loiseau H, Facon T, Harousseau JL, Touzeau C, Perrot A
  • Auteurs (entité) MEULEMAN NATHALIE
  • Revue Blood Cancer J
  • Date de publication 2025-10
35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.
  • Digital and AI-assisted multimodal supportive care, combining physical activity, nutrition, and pain management during chemotherapy for advanced pancreatic cancer patients: study protocol of the European multicenter randomized controlled trial of the RELEVIUM project.

  • Auteurs Hillen B, Oestreicher G, Schwab L, Enders K, Simon P, Elme A, Ben-Aharon I, Goshenlago T, Neuzillet C, Sclafani F, Beltran EEM, Schuster M, Doncheva H, Ruckes C, Karlecik M, Petrowski K, Rosenbaum D, Diou C, Ballas A, Vlachostergiou A, Mastricci D, Scherrer A, Pilz M, Flechsig J, Apostolidis L, Krooupa AM, Chintha S, Musisi IW, Tzavara NP, Kakasis A, Hadjikypri X, Karra S, Chatzipanagiotou K, Drivas I, Dacasa H, Moehler M
  • Auteurs (entité) SCLAFANI FRANCESCO
  • Revue BMC Cancer
  • Date de publication 2025-10
Digital and AI-assisted multimodal supportive care, combining physical activity, nutrition, and pain management during chemotherapy for advanced pancreatic cancer patients: study protocol of the European multicenter randomized controlled trial of the RELEVIUM project.
  • International expert consensus on the clinical integration of circulating tumor cells in solid tumors.

  • Auteurs Nicolò E, Reduzzi C, Pierga JY, Gazzaniga P, Stoecklein NH, Denninghoff V, Rothwell DG, De Bono JS, Marchetti D, Lianidou E, Riethdorf S, Generali D, Hofman P, Gerratana L, Kuhn P, Thiery JP, Ignatiadis M, Bidard FC, Lucci A, Kasimir-Bauer S, Serrano MJ, Cristofanilli M
  • Auteurs (entité) IGNATIADIS MICHAIL
  • Revue Eur J Cancer
  • Date de publication 2025-10
International expert consensus on the clinical integration of circulating tumor cells in solid tumors.
  • Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR.

  • Auteurs Öcal O, Zech CJ, Bali MA, Pasquier D, Mottaghy F, Einspieler I, Kartalis N, Bargellini I, Iezzi R, Denecke T, Kunz WG, Gebauer B, Wege H, Cannella R, Oprea-Lager DE, Vogel A, Sangro B, Seidensticker M
  • Auteurs (entité) BALI MARIA
  • Revue Eur Radiol
  • Date de publication 2025-10
Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR.
  • Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification.

  • Auteurs Borys K, Haubold J, Keyl J, Bali MA, De Angelis R, Boni KB, Coquelet N, Kohnke J, Baldini G, Kroll L, Schramm S, Stang A, Malamutmann E, Kleesiek J, Kim M, Kasper S, Siveke JT, Wiesweg M, Merkel-Jens A, Schaarschmidt BM, Gruenwald V, Bauer S, Oezcelik A, Bölükbas S, Herrmann K, Kimmig R, Lang S, Treckmann J, Stuschke M, Hadaschik B, Umutlu L, Forsting M, Schadendorf D, Friedrich CM, Schuler M, Hosch R, Nensa F
  • Auteurs (entité) DE ANGELIS Riccardo
  • Revue NPJ Digit Med
  • Date de publication 2025-10
Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification.
  • Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.

  • Auteurs Brandão M, Prisciandaro E, Xenophontos E, Mariolo A, Sadeghi AH, Filippi AR, Levy A, Bandura A, Caramella C, Dickhoff C, de Margerie-Mellon C, Faivre-Finn C, Portik D, Sanchez-Lorente D, De Ruysscher D, Smit E, Gobbini E, Fadel E, Ruffini E, Olmetto E, Cortiula F, Bahce I, Houda I, Opitz I, Naidoo J, Edwards J, Remon J, Benitez JC, Trujillo JC, Derks J, Amrane K, Hartemink KJ, Stathopoulos K, Hendriks LEL, Iglesias M, Occhipinti M, Guckenberger M, Giaj Levra N, Girard N, Reguart N, Mercier O, Bironzo P, Hofman P, Petersen RH, De Angelis R, Abgral R, Terrisse S, Popat S, Pierret T, Blum TG, Ricardi U, Dionisi V, Berghmans T, Dingemans AC
  • Auteurs (entité) BERGHMANS THIERRY
  • Revue Lung Cancer
  • Date de publication 2025-10
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.
Erasme hospital

Erasmeziekenhuis

Bekijk alle wetenschappelijke publicaties van Erasme

Huderf hospital

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Bordet hospital

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet